tetano
Editor, Senior Moderator
Arch Med Res
. 2020 May 20;S0188-4409(20)30728-1.
doi: 10.1016/j.arcmed.2020.05.007. Online ahead of print.
Covid-19 Pandemic and Current Medical Interventions
Sweeta Manhas[SUP] 1 [/SUP], Anjali Anjali[SUP] 1 [/SUP], Sheikh Mansoor[SUP] 1 [/SUP], Vikas Sharma[SUP] 1 [/SUP], Ajaz Ahmad[SUP] 2 [/SUP], Muneeb U Rehman[SUP] 2 [/SUP], Parvaiz Ahmad[SUP] 3 [/SUP]
Affiliations
Abstract
First humanoid coronavirus was discovered in the middle of 1960s, the class of viruses are considered to be a huge threat. The first onset of human coronavirus, SARS (SARS-CoV) appeared in 2003 which spanned five continents having lethal effects on human population accompanied by The Middle East Respiratory Syndrome Coronavirus in 2012 with a death rate of 35%. The viruses remain a threat till date and are of serious concern since no vaccine or specified drug therapy has been approbated for treating human coronaviruses. The viruses became a pandemic worldwide with the emergence of Wuhan coronavirus (2019-nCoV). SARS-CoV2 viral manifestation poses a serious human life risk by causing acute lung injury and various respiratory outcomes and has become a global concern. High pathogenicity and transmission rate of the viral strain has become the spotlight of research community throughout the world. With the ongoing studies on viral structure and host interactions, the intricacy of the viral proteome structure and replication cycle proposes a need to explore our understanding of host factors playing role in viral multiplication cycle. This review provides insight into our prevalent perception of coronavirus-host interactions, structure of SARS-CoV2, receptor mediated entry of virus inside the human cells, ongoing clinical trials, drug therapies and treatments that are being used to combat COVID-19 targeting viral fusion, replication and its multiplication.
Keywords: Human coronavirus; SARS-CoV2; Structure; Therapy; Treatments; Virus.
. 2020 May 20;S0188-4409(20)30728-1.
doi: 10.1016/j.arcmed.2020.05.007. Online ahead of print.
Covid-19 Pandemic and Current Medical Interventions
Sweeta Manhas[SUP] 1 [/SUP], Anjali Anjali[SUP] 1 [/SUP], Sheikh Mansoor[SUP] 1 [/SUP], Vikas Sharma[SUP] 1 [/SUP], Ajaz Ahmad[SUP] 2 [/SUP], Muneeb U Rehman[SUP] 2 [/SUP], Parvaiz Ahmad[SUP] 3 [/SUP]
Affiliations
- PMID: 32499154
- DOI: 10.1016/j.arcmed.2020.05.007
Abstract
First humanoid coronavirus was discovered in the middle of 1960s, the class of viruses are considered to be a huge threat. The first onset of human coronavirus, SARS (SARS-CoV) appeared in 2003 which spanned five continents having lethal effects on human population accompanied by The Middle East Respiratory Syndrome Coronavirus in 2012 with a death rate of 35%. The viruses remain a threat till date and are of serious concern since no vaccine or specified drug therapy has been approbated for treating human coronaviruses. The viruses became a pandemic worldwide with the emergence of Wuhan coronavirus (2019-nCoV). SARS-CoV2 viral manifestation poses a serious human life risk by causing acute lung injury and various respiratory outcomes and has become a global concern. High pathogenicity and transmission rate of the viral strain has become the spotlight of research community throughout the world. With the ongoing studies on viral structure and host interactions, the intricacy of the viral proteome structure and replication cycle proposes a need to explore our understanding of host factors playing role in viral multiplication cycle. This review provides insight into our prevalent perception of coronavirus-host interactions, structure of SARS-CoV2, receptor mediated entry of virus inside the human cells, ongoing clinical trials, drug therapies and treatments that are being used to combat COVID-19 targeting viral fusion, replication and its multiplication.
Keywords: Human coronavirus; SARS-CoV2; Structure; Therapy; Treatments; Virus.